Abstract Hyperthyroidism triggers systemic complications, including oxidative stress, dyslipidemia, hepatic injury, insulin resistance, and cardiovascular dysfunction
Many millions of people use GLP-1 RA medicines throughout the world due to their significant health benefits
The prevalence of pediatric MASLD continues to rise in parallel to the rise of obesity in the United States and globally
Either is defensible
This consistency matters enormously for preserving lean mass during weight loss, a challenge that intensifies as body composition shifts
21,22 These observations were predated by substantial preclinical evidence that GLP-1RAs reduce voluntary alcohol consumption and attenuate alcohol reinforcement, 23,24,25,26 suggesting potential clinical applications of GLP-1RAs for AUD